E therapeutics : Interim Results for the financial year 2023

Interim Results for the financial year 2023/2024


Interim results for the six months to 31 July 2023


Six months of progress with positive proof-of-concept data...

Related Keywords

United Kingdom , London , City Of , United States , Michael Bretherton , Ali Mortazavi , Timothy Bretherton , Teos Therapeutics Inc , European Union Withdrawal , Regulatory Information Service , Interim Results , Teos Therapeutics , Chief Financial Officer , Non Executive Director , Non Executive Directors , Chief Executive Officer , Market Abuse Regulations , European Union , Continued Execution , Large Language , East Coast , Markets ,